The Netherlands is one of the original six donors to Gavi and has steadily increased its strong and long-term political and financial support. The Netherlands has taken an active role in Gavi and hosted the first meeting of Gavi’s first replenishment cycle in The Hague in March 2010. The Netherlands is represented on the Gavi Board in the Board Constituency also comprising Denmark, Norway and Sweden.
Contributions to the Vaccine Alliance are channelled through direct contributions, IFFIm, and the Matching Fund. Since 2001, The Netherlands has contributed USD 365 million to Gavi in direct contribution. The Netherlands joined IFFIm in 2009, demonstrating its interest in innovative financing for development with a EUR 80 million commitment (2009-2016). The Dutch Postcode Lottery has also provided funding to Gavi.
Note: Proceeds are funds made available to Gavi from donor contributions and commitments, either through cash payments made to Gavi, through frontloading via the capital markets of a future donor commitment to IFFIm, or through AMC funds released to Gavi via the World Bank. IFFIm proceeds are allocated over five year periods coinciding with Gavi’s strategic periods. Proceeds for the current and future strategic periods are indicative until the end of each period and could be revised following changes in market conditions (interest rates or foreign exchange rates), the signing of new pledge(s) and/or changes in IFFIm’s disbursement profile.
Click on Direct, IFFIm, AMC or Matching Fund in the above key to toggle their data on the graph, click again to show the data
Direct Contributions (including Matching Fund)
Received contributions: non-US$ contributions for 2000-2018 and Q1-Q3 2019 are expressed in US$ equivalents using the exchange rates on the dates of receipt. For 2014-2018 and Q1-Q3 2019, where contributions were hedged to mitigate currency risk exposure, these have been expressed using the rates applicable to the hedge agreement.
Future contributions: non-US$ Direct Contribution and Matching Fund pledges for Q4 2019 and years 2020 and beyond are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 September 2019 or using the rates applicable to any hedge agreement in place.
Received contributions: non-US$ contributions for 2000-2018 and Q1-Q3 2019 are expressed in US$ equivalents as confirmed by the IBRD (World Bank)
Future contributions: non-US$ contributions for Q4 2019 and years 2020 and beyond are expressed in US$ equivalents as follows:
Where the contribution agreement has been signed: contributions are expressed in US$ equivalents using the exchange rates at the time of signing the respective donor grant agreements
Where the contribution agreement has not yet been signed: contributions are expressed in US$ equivalents using the applicable 'forecast rates' from Bloomberg as at 30 September 2019
While IFFIm grants are irrevocable and legally binding, they are subject to a Grant Payment Condition that can potentially reduce the amount due in the event that a programme country is in protracted arrears with the International Monetary Fund. As of 30 September 2019, IFFIm donor grant payments are reduced by 1.5%, however such reductions are not reflected in future contributions figures.
At the pledging conference in London in 2011, The Netherlands committed EUR 120 million (USD 149 million) through a long-term grant agreement for the period 2011-2015. In Berlin 2015, the Minister for Foreign Trade and Development Cooperation announced a 25% increase in the Dutch contribution to the Vaccine Alliance totalling EUR 249.5 million for the period 2016-2020, which includes increased direct contributions, an IFFIm extension and a new contribution of EUR 10 million to the Gavi Matching Fund.
Contributions and pledges in total: